Microglia are tissue-resident macrophages of the CNS that orchestrate local immune responses and contribute to several neurological and psychiatric diseases. Little is known about human microglia and how they orchestrate their highly plastic, context-specific adaptive responses during pathology. Here we combined two high-dimensional technologies, single-cell RNAsequencing and time-of-flight mass cytometry, to identify microglia states in the human brain during homeostasis and disease. This approach enabled us to identify and characterize a previously unappreciated spectrum of transcriptional states in human microglia. These transcriptional states are determined by their spatial distribution, and they further change with aging and brain tumor pathology. This description of multiple microglia phenotypes in the human CNS may open promising new avenues for subset-specific therapeutic interventions. NATuRE NEuROSCiENCE | VOL 22 | DECEMBER 2019 | 2098-2110 | www.nature.com/natureneuroscience 2098
T he CNS hosts a heterogeneous population of myeloid cells, including parenchymal microglia and non-parenchymal perivascular, meningeal and choroid plexus macrophages referred to as CNS-associated macrophages (CAMs) [1] [2] [3] . While CAMs constitute an immunological barrier at CNS interfaces, microglia fulfill context-dependent functions during development, adulthood and aging 4 . In the healthy brain, microglia are involved in the surveillance and maintenance of the microenvironment, the modulation of synaptic plasticity and the removal of dying cells 5, 6 . In the diseased brain, microglia have immunological functions, such as immune cell recruitment and cell debris removal 1-3 , but not antigen presentation to encephalitic T cells 7 . Moreover, genome-wide association studies of patients with neurodegenerative disorders or neuroinflammatory conditions have revealed that many of the riskassociated single nucleotide polymorphisms are linked to microglia, which suggests that there is an important role for innate immune cells in CNS diseases.
It is conceivable that the distinct and highly diverse functions of microglia are performed by specialized microglia subsets. However, evidence for the existence of such microglia subsets in vivo is scarce. In fact, the most salient questions regarding the single-cell composition of microglia states in the human brain, such as regional and functional heterogeneity, remain unanswered to date. Traditional approaches for profiling microglia were limited in their ability to resolve microglia heterogeneity due to a narrow set of examined features or the need to pool large cell numbers [8] [9] [10] . Recent studies using laboratory mice have utilized single-cell-based immune phenotyping by time-of-flight mass cytometry (CyTOF) and single-cell RNAsequencing (scRNA-seq) to profile the heterogeneity of microglia and other CAMs in the mouse. CyTOF revealed novel microglia markers in mouse models of aging, demyelination and inflammation 11, 12 . scRNA-seq was instrumental in enabling the profiling of murine CNS cells, including microglia [13] [14] [15] , across different sexes and developmental stages [16] [17] [18] [19] [20] . Additionally, neurodegeneration-associated microglia phenotypes were recently characterized in the mouse using this methodology 21, 22 . Due to obvious difficulties in obtaining healthy human brain samples, few datasets at the single-cell level are currently available for transcriptomic 23, 24 and phenotypic 25 signatures of healthy developing and adult human microglia. However, an overall comparison between results obtained using scRNA-seq and CyTOF, to our knowledge, has never been performed for the CNS. While several studies have profiled human gliomas [26] [27] [28] [29] [30] , as well as neuroinflammatory 18, 31, 32 , neurodevelopmental 33 and neurodegenerative diseases 34 , conclusions about microglia diversity cannot readily be drawn from these datasets due to the limited numbers of cases or the lack of controls.
Here, we profiled 4,396 microglial cells from control brain regions of 15 adults that underwent surgery for epilepsy or tumors. We utilized the 3′-end-based mCEL-Seq2 protocol 35, 36 followed by the RaceID algorithm, which is designed to identify rare cell populations. Notably, one-third of all cells displayed an enrichment for the microglial core signature reported in bulk RNA-seq studies 9, 10 . more than 50% of microglia assigned to C2 and C3. The differences in percentages might be due to technical aspects, such as differences in single-cell protocols (nuc-seq compared to mCEL-Seq2), or to the different ages of the patients (the mean ages were 44 years for Masuda et al. 18 , 13 years for Velmeshev et al. 33 , 53 years for Schirmer et al. 32 , 58 years for Jäkel et al. 31 and 87 years for Mathys et al. 34 ). Interestingly, in the pediatric cohort of Velemshev et al. 33 , most cells were assigned to C2, whereas microglia were predominately assigned to C3 in the adult datasets. Finally, in the geriatric population examined by Mathys et al. 34 , C6 represented the single largest cluster. The absence of certain clusters in the Schirmer et al. 32 and Jäkel et al. 31 datasets is likely due to the relatively low cell numbers. the healthy human brain by scRNA-seq. a, Schematic depicting the workflow for the isolation of single CD45 + DAPI − cells from the temporal lobe of healthy human subjects for scRNA-seq. A total of 4,564 CD45 + cells from 15 individuals were analyzed. b, t-SNE representation of all cells, including microglia, monocytes, oligodendrocyte precursor cells and T cells, from which 4,396 microglia cells were selected for further analysis. c, Heatmap of the 20 most differentially upregulated genes per cluster (adjusted P value of <0.05 based on the negative binomial distribution) with C3 showing differential expression of genes such as CX3CR1, C2 of genes encoding MHC-II molecules such as HLA-DRA, C6 and C7 of SPP1 and C1, C5, C8 and C9 of CCL2 and CD83. The scale bar represents the color-coded z-scores. n = 4,396 cells from 15 samples were analyzed. Differentially expressed genes were assessed based on a negative binomial distribution. d, Stacked bar plot (Marimekko chart) of the abundance of cells from individual patients per cluster. Note that clusters of all subjects contribute to C2 and C3. The color scale underneath indicates colors representing individual patients. Ordering of the patients is based on their age. e, t-SNE representation of the cells with color-coded clusters. Color-coding of the clusters is indicated underneath. f, Pie chart showing the relative size of each cluster and the respective number of cells per cluster. Color-coding is consistent with e. g, Comparative analysis of the present dataset with published microglia datasets using a neural-network-based classifier. Depicted is a Marimekko chart with the training dataset as reference on the left followed by classifier-based and color-coded cluster assignments of the test dataset and published datasets 18, [31] [32] [33] [34] . The cell numbers of each dataset are provided above the chart. h, t-SNE map color-coded for transcript counts (left) and the corresponding single-cell bar plots (right) of genes enriched in subsets of microglia. Color-coding is consistent with d. FACS  of CD45 + Dapicells into 384-well  plates   Sequencing, unbiased  clustering and identification  of subsets   Protein validation:  immunohischemistry  CyTOF   C5  C8  C1  C9  C6  C7  C2  C3   C2orf68  LCLAT1  AC007743.1  ADGRG1  C1QB  GIMAP1  TMEM119  LMOD3  TCTN1  TBCK  CCDC168  XIRP1  ATXN3  TPTEP1  GIMAP7  PSAP  C1QA  IGKC  HTRA1  CD300E  C3  CST3  OPHN1  CX3CR1  SELPLG  C1QC  FOLR2  GAL3ST4  MARCKS  ITM2C  MARCH1  HAMP  MAF  IER3  CCL2  TNF  NR4A2  CCL8  IER2  CH25H  IL1B  BTG2  IL1RN  IL1A  B3GNT5  EGR1  EGR3  EGR2  OTUD1  SRGN  MCL1  DBI  CD83  CCL3L3  CDKN1A  SGK1  KLF6  CCL4  EDN1  SAT1  NR4A3  GADD45B  CCL4L2  PTGS2  FCER1A  DDX3Y  IER5  NEDD9  CXCL8  HLA-DQB1  HLA-DQA1  HLA-DRA  HLA-DPB1  HLA-DPA1  VEGFA  PIWIL1  SERPINE1  MAFB  FGL2  IFI44L  H3F3A  ADAM10  SAMHD1  VIM  HLA-DRB1  CD74  HLA−DMA  BHLHE40  LIPA  PADI2  SLC11A1  LPL  CEBPD  HLA-B  HLA-C  HLA-A  B2M  TMSB10  FKBP5  FTL  SLC44A2  APOE  GLDN  ASAH1  CD44  CTSD  LGALS9  LCP1  VSIG4  CACNA1A  LHFPL2  PDK4  SPP1  ID2   T cells  Oligodendro- 
ResouRce

NATuRE NEuRoSCiENCE
Consistent with our dataset, all datasets contained substantial percentages of cells assigned to the proinflammatory clusters C1, C5, C8 and C9, which suggests that there is a potential in vivo relevance of these clusters.
Gene set enrichment analysis suggests diverse functional states of human microglia. To assess the functional states of the identified microglia clusters, we performed gene ontology (GO) enrichment analysis based on cluster-enriched gene sets ( Fig. 2a,b ; 51 . Selected terms are represented in a dot plot, with the size of the dot corresponding to the number of genes per term and the color of the dots corresponding to the q value of enrichment after -log 10 transformation. n = 4,396 cells from 15 subjects were analyzed. Differentially expressed genes were assessed based on a negative binomial distribution. Hypergeometric testing was conducted for enrichment analysis. q values were calculated to control for multiple testing. b, t-SNE expression plots color-coded for the aggregated transcript counts of genes summarized by representative GO terms enriched in a given cluster are presented. c, t-SNE expression and line plot of the microglial homeostatic gene signature consisting of CX3CR1, TMEM119, CSF1R, P2RY12, P2RY13, SELPLG and MARCKS. Note that the homeostatic gene signature is prominent in the clusters C2 and C3.
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Supplementary 6 ). Clusters C2, C6 and C7 were characterized by a high MHC-II-associated gene signature corresponding to the GO term "antigen processing and presentation of peptide antigen". Clusters C1, C5, C8 and C9 showed GO term enrichment for "positive regulation of chemotaxis" and "positive regulation of MAPK cascade". Previously published microglial core signature genes 39, 40 , including CX3CR1, TMEM119, CSF1R, P2RY12, P2RY13, SELPLG and MARCKS, were expressed by all clusters, with the highest expression levels for clusters C2 and C3 ( Fig. 2c ; Extended Data Fig. 6 ).
Region-dependent and age-dependent microglial heterogeneity in the human CNS. Next, we sought to examine variables underlying the microglia heterogeneity. Previous microarray studies of bulk RNA have shown age-dependent and brain-region-dependent microglia heterogeneity in mice 10, 41 . We were able to obtain two distinct anatomical locations from the human CNS, namely temporal lobe gray and white matter from 11 out of 15 individuals. To analyze the effects of different brain regions on microglial phenotypes, we compared the expression of different microglial immune markers between gray and white matter ( Fig. 3a ; Extended Data Fig. 1 ; Supplementary Table 5a ,b). A quantitative analysis of brain sections showed a consistently higher expression of immune markers in white matter compared with gray matter microglia ( Fig. 3b ). After normalizing for IBA1 + cell counts, expression of HLA-DR and CD68 was significantly higher in white matter microglia ( Fig. 3c ). Color-coding the origin of the single-cell transcriptomes revealed a good match with the immunohistochemical in situ results ( Fig. 3d ). Gray matter microglia were enriched in the MHC-II low clusters C3 and C8 ( Fig. 3e ). Conversely, white matter microglia were overrepresented in the MHC-II high clusters C2 and C5-C7 ( Fig. 3e ). Furthermore, high expression of the lysosomal marker CD68 in white matter microglia suggests an involvement of these microglia in oligodendrocyte maintenance, as previously reported 42, 43 . To further validate these findings on the protein level, we conducted CyTOF analysis of five gray matter and four white matter samples ( Fig. 3f ,g). The CyTOF antibody panel consisted of relevant myeloid cell protein markers for which antibodies were available 25 ( Supplementary Tables 6 and 7 ). This analysis revealed two distinct microglia clusters ( Fig. 3f ). Consistent with the scRNA-seq results, higher expression levels of HLA-DR, APOE, CD68 and EMR1 were detected by CyTOF in white matter microglia compared with gray matter microglia ( Fig. 3g ).
We next assessed the influence of age on microglia phenotypes. To this end, we divided the patients into three age bins (<30 years, 30-50 years and >50 years) and analyzed the cluster composition within these age bins ( Fig. 3h ,i; Supplementary Table 1 ). Interestingly, age bin <30 years (four individuals) was enriched in cluster C3 as were C1, C5, C8 and C9, whereas clusters C6 and C7 were almost absent ( Fig. 3i ). In contrast, the age bin >50 years (three individuals) was enriched in clusters C6 and C7 (Fig. 3i ). The age bin 30-50 years (three individuals) was enriched in cluster C2 (Fig. 3i ). As shown above, the SPP1 gene showed higher expression in clusters C6 and C7 (Fig. 1c ,h) and enrichment in the age bin >50 years. SPP1 encodes for a proinflammatory cytokine (osteopontin) that plays a pivotal role in neuroinflammation 44 . An immunohistochemical analysis of ten brain samples without pathology revealed a region-dependent and age-dependent increase of SPP1 + IBA1 + cells, with higher percentages in white matter compared with gray matter (paired two-sided t-test P = 0.043; Fig. 3j ) and enrichment in the age bin >50 years (gray matter: Spearman's R 2 = 0.73, P = 0.002; white matter: Spearman's R 2 = 0.54, P = 0.16; Fig. 3j , Extended Data Fig. 7) , which is consistent with the scRNA-seq data.
Taken together, using scRNA-seq along with immunohistochemistry and CyTOF analyses of protein expression, we found three distinct region-dependent microglia phenotypes in the human temporal lobe with region-dependent and age-dependent variations of immune regulatory genes.× Existence of disease-associated microglia clusters in human gliomas. Gliomas are diffusely growing brain tumors derived from astroglial or oligodendroglial precursor cells that typically show robust innate immune infiltration consisting of myeloid cells of diverse entities 45 . While a number of studies have profiled malignant glioma cells [26] [27] [28] [29] [30] , detailed assessments of glioma-associated changes in human microglia were not possible due to a lack of healthy control tissue in these studies. We hence profiled microglia from four isocitrate dehydrogenase (IDH) wild-type primary glioblastomas and compared them with microglia from four age-matched controls (Extended Data Fig. 8 ; Supplementary Table 8a ,b). Unsupervised clustering revealed 1,853 cells, including microglia, monocytes, T cells and oligodendrocytes ( Fig. 4a ; Extended Data Fig. 9 ). An analysis of 1,701 microglia yielded 14 distinguishable clusters spanning a continuum from control-enriched clusters (C9, C11 and C12) to mixed clusters (C3-C7 and C10) and clusters that were non-diseased human brain. a, Representative microscopy images of immunoreactivities for the proteins expressed by microglia that were examined in this study. Experiments were repeated on 15 independent control samples. b, Quantification and statistical analysis using one-sided paired t-tests showed a consistent upregulation of proteins expressed by microglia in the white matter (WM) compared with the gray matter (GM). Data of n = 11 to n = 15 samples are provided; each circle represents an independent sample. Significant P values are provided for one-sided paired t-test followed by Benjamini-Hochberg correction for multiple testing. c, Normalization of the quantification showed that HLA-DR + and CD68 + cells were enriched in the white matter compared with the gray matter. Data of n = 11 to n = 15 samples are provided; each circle represents an independent sample. Significant P values are provided for one-sided paired t-test followed by Benjamini-Hochberg correction for multiple testing. The boxplots span the 25th to 75th percentiles and the whiskers represent 1.5 times the interquartile range. The bold lines indicate the median. d, t-SNE representation with color-coding of the region from which the cells were isolated. Cells from samples in which separation of gray and white matter tissue was not possible are not shown. e, Marimekko chart showing the cluster-wise distribution of cells color-coded for the region from which they were isolated. n = 11 independent samples were analyzed. P values are provided for significantly enriched regions per cluster, based on hypergeometric tests. Benjamini-Hochberg correction was applied to correct for multiple testing. f, CyTOF analysis of five samples from control gray matter and four samples from control white matter reveals region-specific clustering as shown by the viSNE plot with color-coding for the region from which the sample was obtained. g, Representative t-SNE plots of CyTOF data with color-coded expression of the respective protein markers and quantitative analysis of the sample-wise mean expression values reveal higher expression of APOE, HLA-DR, EMR1 and CD68 in white-matterderived microglia. P values <0.05 are provided for one-sided unpaired t-tests followed by Sidak-Bonferroni correction for multiple testing. Data from five samples from control gray matter and four samples from control white matter are provided; each circle represents an independent sample. h, t-SNE plot color-coded for patient age suggests enrichment of samples from >30-year-old subjects in the clusters C6 and C7. i, Marimekko chart showing the age distribution across clusters. n = 15 independent samples were analyzed. P values are provided for significantly enriched age bins per cluster, based on hypergeometric tests. Benjamini-Hochberg correction was applied to correct for multiple testing. j, Dot-bar plots showing increased age-dependent and region-dependent positivity based on immunohistochemistry for SPP1 protein in microglia. n = 10 independent samples were analyzed. The bar plots depict sample means and the error bars represent standard errors of the mean. Differential gene expression analysis of the glioma-associated clusters C13 and C14 revealed low expression of microglia core genes, including CX3CR1 and SELPLG, whereas metabolic, inflammatory and interferon-associated genes, such as CD163, APOE, LPL, IFI27 and IFITM3, were more highly expressed compared with cells from adjacent clusters ( Fig. 4d ,g; Extended Data Fig. 10 ; Supplementary  Table 9 ). Some cells showed high expression of hypoxia-associated genes, such as HIF1A and VEGFA ( Fig. 4d ,g; Extended Data Fig. 10 ). GAMs were enriched in clusters C3-C7 and C10, with substantial contributions from controls ( Fig. 4c ,e-g). These cells showed similar expression of SPP1 compared with C13, and higher levels than the control-enriched clusters C9, C11 and C12 ( Fig. 4d-f ). Marked differences in the contribution of individual samples to the clusters C13 and C14 are likely due to the pronounced regional heterogeneity of GBMs, which are a patchwork of solid tumor, hemorrhages and tumor necroses reflected in the tumor-specific term 'multiforme' . We found low expression of microglia core signature genes (for example, CX3CR1) in the clusters C13 and C14, high expression of the hypoxia-associated gene VEGFA in C10 and higher expression levels of the interferon gene IFI44 in C13 compared with the adjacent clusters C3-C7 ( Fig. 4g ; Supplementary Fig. 1 ). A GO term analysis of the differentially expressed genes revealed an enrichment of the term "positive regulation of vasculature development" in C14 and C10 ( Fig. 4g ; Supplementary Fig. 2 ; Supplementary  Table 10a ,b). The remaining GAM-associated clusters showed an enrichment of the GO term "antigen processing via MHC class I" ( Fig. 4h ; Supplementary Fig. 2) . We then validated and tested the reproducibility of our findings by comparing our data with an independent dataset from Darmanis et al. 26 , which used a different scRNA-seq protocol. We implemented a deep neural network classifier on our dataset that consisted of GAMs and control cells and used the workflow described above (Extended Data Fig. 5a ). The accuracy of the resulting classifier was 0.91 on the training set and 0.55 for the test set ( Supplementary Fig. 3a ). Next, we used the classifier on the Darmanis et al. dataset 26 . The training and test sets are shown as reference ( Supplementary Fig. 3b ). Microglia from Darmanis et al. 26 (n = 380) were devoid of cells assigned to C3, C11 and C13. The majority of this dataset was assigned to C5, C1 and C14 (37.6%, 27.9% and 13.7% of the cells, respectively). Furthermore, 8.9% of the cells were assigned to C4, 3.2% to C8, 2.1% to C2 and C10, 1.3% to C12 and less than 1% to C6 and C9 ( Supplementary Fig. 3b ). Taken together, the classifier assigned 64.9% of the Darmanis et al. dataset 26 to the GAM-enriched clusters C3-C7, C10 and C14. The de-enrichment of the homeostatic-enriched clusters C11 and C12 can be explained by the lack of control cells in that study. Notably, both datasets contained cells assigned to C14. The lack of cells (such as C13) may be due to technical factors, such as differences in the scRNA-seq protocol, the low number of sampled cells or tumor heterogeneity. Taken together, GAMs show transcriptomic changes with respect to control cells that were confirmed in an independent dataset 26 .
In situ characterization of glioma-associated microglia. To further explore the differences between GAMs and control microglia in situ, we studied the expression of immune molecules on human microglia by immunohistochemistry ( Fig. 5a -c; Supplementary  Fig. 4 ). We found higher numbers of cells expressing immune markers in GBM samples ( Fig. 5b) . Normalization for the number of IBA1 + cells revealed lower expression of the bona fide microglial markers P2RY12 and TMEM119, and higher expression of HLA-DR ( Fig. 5c ). It should be kept in mind that IBA1 (encoded by AIF1) is a pan-myeloid cell marker that is also expressed on infiltrating myeloid cells. t-SNE plots of color-coded genes encoding the above-mentioned proteins revealed expression across all clusters ( Fig. 5d ). Given that GAMs are enriched in the single-cell clusters C3-C7, which have a considerable contribution from control samples ( Fig. 4f-g) , we considered that GAMs may resemble agingassociated microglia. As SPP1 was differentially expressed in agingassociated microglia (Fig. 3j) , we evaluated the protein expression of SPP1 in GBM samples with respect to control white matter from four age-matched subjects >50 years of age ( Fig. 5e-g) . Indeed, the percentage of IBA1 + SPP1 + cells was more than double in GBM samples compared with controls ( Fig. 5f ). This was consistent with SPP1 gene expression in the GAM clusters ( Fig. 4d ). Overall, GAMs showed a context-specific phenotype that was transcriptionally related to aging-associated microglia.
Characterization of glioma-associated microglia using pseudotime analysis and CyTOF. So far, we have identified a transcriptional continuum consisting of GAMs co-clustering with aging-associated microglia (clusters C6 and C7 in Fig. 4f ), which in turn share similarities with MHC-II high homeostatic microglia ( Fig. 2a,b ), but with the additional expression of inflammatory and metabolism genes such as SPP1 and APOE (Figs. 1c and 5g). To quantitatively assess the gradual gene expression changes in this transcriptional continuum, we applied the StemID2 algorithm 37 . This algorithm analyzes gradual transcriptional changes by placing single-cell transcriptomes on a pseudotemporal trajectory whereby neighboring cells are transcriptionally similar, but the overall trajectory is directed from one cell state over transitional states toward a final state. In an unsupervised manner, StemID2 suggested a trajectory of C11→C12→C3→C6→C5→C13, leading from the homeostatic via aging-associated to the GAM clusters ( Supplementary  Fig. 5 ). The resulting heatmap showed a gradual downregulation of microglial homeostatic genes (including CX3CR1 and CSF1R) and a concomitant upregulation of inflammatory and metabolism genes (including TREM2 and APOE) with enrichment of the associated GO terms ( Fig. 6a ; Supplementary Table 11 ). Importantly, we obtained a similar result using the independent pseudotime analysis tool Monocle 46 ( Supplementary Fig. 6 ).
Next, we used CyTOF to determine whether the transcriptional changes are also found on the protein level ( Fig. 6b-g ). To exclude contamination by infiltrating peripheral cells, we gated the analyzed cells on the bona fide microglia markers P2RY12 and TMEM119 ( Supplementary Fig. 7 ). Notably, GAMs clustered distinctly from control microglia (Fig. 6b ). While fewer cells from the control samples were found in the GAM cluster, some GBM samples contributed substantially to the control cluster ( Fig. 6c ), which may reflect aging-related control microglia subsets within the GBM samples. Overall, the transcriptomic pattern of GAMs was reproduced on the C14  C13  C10  C7  C1  C4  C3  C6  C2  C5  C11  C12  C8  C9   LYVE1  MRC1  ITPR2  IPCEF1  MARCKS  P2RY13  IL6ST  ACY3  LPAR5  GATM  P2RY12  ITM2C  CX3CR1  SELPLG  DHRS9  A2M  HTRA1  BIN1  IDH2  PTAFR  ALDH2  HLA−DRB5  CYFIP1  TXNIP  IFI27  MX1  SCIN  FKBP5  CPM  IFITM3  IFI6  EIF2AK2  IFI44L  IFI44  IFIT3  PLAC8  CLEC5A  LDHA  PADI2  SLC11A1  MSR1  CEBPD  CXCR4  ACSL1  CD163  FCGBP  MAFB  APOE  APOC1  WIPF3  CPVL  NAP1L1  VSIG4  GLDN  DDIT4  SPP1  CACNA1A  SERPINE1  FTL  LPL  GPNMB  TPT1  HIF1A  NAMPT  ELL2  VEGFA  MT2A  C5AR1  PLAUR  HBEGF  TFRC  IL1RN  MCL1  SGK1  CD83  NR4A2  SRGN  NR4A3  PDK4  CDKN1A  OTUD1  B3GNT5  CH25H  IER3  CCL2  TNF  CCL8  PTGS2  EGR1  BTG2  IL1B  EGR3  EGR2  IL1A  CCL4L2  CCL3L3 ResouRce NATuRE NEuRoSCiENCE protein level ( Fig. 6d-f ). Specifically, we found higher expression of HLA-DR, TREM2, APOE, GPR56 (also known as ADGRG1) and a number of other proteins such as GLUT5 and CD64 ( Fig. 6f,g ; Supplementary Fig. 8 ; Supplementary Table 12 ). Conversely, genes with lower expression on the transcriptomic level (CX3CR1, CSF1R and FCGR1A) were unchanged or even showed higher expression on the protein level ( Fig. 6g ), which may be related to different protein turnover and post-transcriptional regulatory mechanisms. Overall, CyTOF reliably confirmed the major differences between control microglia and GAMs, for example, between the homeostatic microglia clusters C11 and C12 and the GAM clusters C3-C7 and C13 (Fig. 4f ). Our findings provide, to our knowledge, the first combined assessment of gene and protein expression using scRNA-seq plus CyTOF in human microglia from control brains and brain tumors.
Discussion
By combining unsupervised scRNA-seq and CyTOF analyses, we studied the complexity of the microglia landscape in the human brain at the single-cell level. Our data reveal compartment-, ageand disease-specific microglia states with high plasticity emerging in gliomas.
In this study, we addressed unresolved questions in the field. The known diverse context-dependent functions of microglia under neuropathological conditions have long suggested the existence of specialized microglia states. Here, we applied two high-throughput single-cell techniques to conduct a census of human microglia. Our results suggest a spectrum of microglia phenotypes in health and disease. Recent studies that profiled brain tumors have provided valuable insights into tumor biology, but failed to characterize disease-associated microglia subsets 26, [28] [29] [30] . Our study makes an important step toward filling these gaps and provides integrated single-cell transcriptomic and protein expression profiles of GAMs.
We show here that during homeostasis, microglia are positioned on a transcriptional spectrum between high expression levels of the previously published core signature consisting of CX3CR1, TMEM119, CSF1R, P2RY12, P2RY13, SELPLG and MARCKS genes 39, 40 and lower expression of this signature with increased expression of MHC-II and lipid-metabolism-related genes. Microglia located in the gray matter tended toward the former end of the spectrum, while white matter microglia were positioned on the latter end of it. Furthermore, approximately one-tenth of the human microglia expressed chemotactic and proinflammatory genes, such as CCL2, CCL4 and IL1B. It is tempting to speculate that these microglia phenotypes may be involved in cross-talk with the peripheral immune system during CNS damage, while the remaining microglia subsets may support brain maintenance. Comparison with independent datasets confirmed the changes that microglia acquire during aging and disease. A majority of the clusters identified in this study were present in different independent datasets. The distinction of white and gray matter human microglia detected by scRNA-seq was confirmed on the protein level by CyTOF. Notably, white matter microglia expressed higher levels of HLA-DR, CD68, APOE and EMR1 than gray matter microglia. Recent evidence of involvement of microglia in oligodendrocyte maintenance in developing 42, 43 and aging rodent brains 47 supports the notion of functional differences between white and gray matter microglia. In this scenario, blockade of microglia-mediated phagocytosis through inhibition of Rab7 resulted in enhanced accumulation of myelin products in microglial endosomes. In line with these results obtained in rodents, several human microgliopathies display severe white matter changes 3 . These include sclerosing leukoencephalopathy in Nasu-Hakola disease 48 and diffuse leukoencephalopathy in hereditary diffuse leukoencephalopathy with spheroids 49 .
In addition to the transcriptional continuum of microglia in the healthy CNS, we detected heterogeneity of GAMs. The role of microglia in glioma biology remains controversial, ranging from a mere bystander to a crucial promoter function of microglia for glioma growth 45 . We found that GAMs progressed further away from the homeostatic end of the transcriptional continuum, displaying lower expression of the microglial core signature and higher expression of proinflammatory and metabolic genes, including SPP1, and several type I interferon genes, including APOE and CD163. The GAM signature was substantially different from homeostatic microglia and was replicated in an independent scRNA-seq dataset 26 . Notably, CyTOF analysis confirmed the protein expression of the highly expressed genes found in the scRNA-seq analysis of GAMs, including HLA-DR, TREM2, APOE, CD163 and GPR56. Additionally, mass cytometry revealed significant expression of proteins with low transcript abundance that could not be properly assessed in the current scRNA-seq analysis (for example, CD68, CD44, CD116 and IL-6), making the case for the synergy of both techniques. Interestingly, proteins encoded by genes with low transcriptome levels (for example, CX3CR1, CSF1R and FCGR1A) were unchanged in the CyTOF analysis. Future studies using larger sample sizes will elucidate the interplay of gene and protein expression in the context of GBM.
A crucial issue for translational research is the similarity between human and murine microglia. We and others have recently conducted in-depth transcriptional analyses of murine microglia 7, [16] [17] [18] [19] [20] [21] [22] and a few human microglia 18, [31] [32] [33] [34] . We found broad similarities of these cells with homeostatic and disease-associated human microglia, particularly with respect to gradual disease-associated transcriptional changes in both species. However, we also detected subtle differences. Notably, the HEXB gene appears to be less prominently expressed in homeostatic human microglia compared to Hexb in murine microglia (data not shown). In neurodegenerative and neuroinflammatory disease models, murine microglia show upregulation of metabolism and inflammatory genes, such as Spp1 and Apoe 7,18-20 . We also found that these genes were upregulated in 
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GAMs and in aging-associated microglia. However, GAMs also showed context-dependent upregulation of other genes, including CD163 and VEGFA. Finally, a consistent proinflammatory signature has been described across different murine microglia single-cell and bulk RNA-seq studies. Notably, some microglia states expressed higher levels of cytokines and chemokines such as Ccl2 and Tnf 50 . We observed that approximately 10% of human control microglia and GAMs shared this proinflammatory gene signature with murine microglia, but the biological significance of this remains unclear.
While providing novel findings on adult human microglia, our study leaves some open questions. Although we controlled for batch effects in our experimental design and used RaceID functionality, we cannot exclude these effects on our data. The brain regions available for analysis were restricted by the availability of good-quality ResouRce NATuRE NEuRoSCiENCE surgery tissue. A comparison with other brain regions, such as the hippocampus, the striatum or the cerebellum, will be informative in future studies. As our dataset represents a snapshot of microglia, we were not able to distinguish whether the subsets represent cell states or cell types. The former notion would enable a given cell to shift between states when necessary, while the latter would signify a commitment to a particular cell type. This issue could be addressed with longitudinal cell tracking methods, which are difficult to implement CD11c  CD116  CD44  HLA-DR  IRF4  CD91  CD68  CD18  CD33  CD45  Ki67  CD95  APOE  IL−6  CD163  CD47  CD274  GPR56  TREM2 GAM Control 
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in humans without disturbing the system. The isolation of microglia performed in our study is associated with loss of spatial information. Novel multiplexed hybridization methods may help overcome this limitation in the future.
In conclusion, we believe that the identification of microglia heterogeneity in the human brain improves our understanding of microglia biology and may facilitate the development of new compounds to treat microglia-mediated CNS diseases. The characterization of GAMs may help to develop new therapies for gliomas based on the specific targeting of microglia subsets.
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Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/s41593-019-0532-y. Fig. 6 | Characterization of human brain-tumor-linked microglia clusters by CyTOF. a, Pseudotemporal ordering of single-cell transcriptomes using StemID, with transcriptionally similar nodes on the y axis and single-cell transcriptomes arranged along the x axis, based on a pseudotemporal ordering on a trajectory from a control to a GBM-affected brain. Next to the diffusion map are representative genes from the given nodes and GO terms significantly enriched in these nodes. The color bar represents the z-score for the gene expression across the pseudotime trajectory. b, CyTOF analysis of 11 control and 13 GBM samples reveals distinct clustering of cells from each condition. c, Stacked bar plot showing the relative contribution of microglia from each control and GBM sample to the control and glioma cluster from b. d, t-SNE plots for representative protein markers assessed using CyTOF. e, A heatmap representation of protein expression shows distinct clustering of control microglia and GAMs. f, Overview of protein markers encoded by genes (symbols in parentheses) with higher expression along the pseudotemporal trajectory from a. Proteins with P < 0.05 using one-sided unpaired t-tests are shown. Data are provided on n = 11 control and n = 13 GBM samples. Mean expressions are color-coded for each sample; each circle represents an independent sample. g, Overview of protein markers encoded by genes (symbol in parentheses) with lower expression along the pseudotemporal trajectory from a. P values are provided for one-sided unpaired t-tests followed by Sidak-Bonferroni correction for multiple testing. Data on n = 11 control and n = 13 GBM samples are displayed. The horizontal lines represent the mean; each circle represents an independent sample.
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Methods Prospective tissue collection. Radiologically healthy brain tissue samples from 15 individuals (7 females and 8 males aged 14-74 years; 14 temporal, 1 frontal lobe) undergoing brain surgery for epilepsy, glioma or metastasis, were placed in ice-cold PBS immediately after resection. Stained cryosections were examined by a fully trained neuropathologist. No statistical methods were used to predetermine sample sizes, but our sample sizes were similar to those reported in previous publications 9, 18, 20, 25, 29, 31, 32 . Control tissue samples from glioma and metastasis surgeries were selected based on radiological appearance and localization of >2 cm from the lesion. After absence of pathologies was confirmed, the control cases were included in the study. To assess glioma-associated changes in microglia, four IDH wild-type GBM, grade WHO IV, were examined. All experiments were conducted in accordance with the institutional review board of the University of Freiburg Medical Center.
Histology. Data collection and analyses were performed blind to the conditions of the experiments. Formalin-fixed-paraffin-embedded tissue samples were sectioned into 3-µm sections, and immunohistochemistry for the microglial markers IBA1 (Wako, Japan), HLA-DR (clone CR3/43, Agilent Dako), TMEM119, P2RY12, CD74, CD68 (clone PG-M1, Agilent Dako), GFAP (glial fibrillary astrocytic protein), pan-cytokeratin and CD3 was conducted for in situ validation. Cresyl violet was used for counterstaining. All image analyses were conducted by an experimenter blinded to the source of the samples.
Immunofluorescence. Data collection and analyses were performed blind to the conditions of the experiments. Formalin-fixed-paraffin-embedded sections were blocked and permeabilized with PBS containing 5% normal donkey serum and 0.5% Triton-X 100 for 1 h at room temperature. Primary antibodies were incubated overnight at a dilution of 1:500 for IBA1 (Abcam) and SPP1 (Merck). Secondary antibodies were added as follows: Alexa Fluor 405 at 1:250 dilution, Alexa Fluor 488 at 1:500 dilution, Alexa Fluor 568 at 1:500 dilution and Alexa Fluor 647 at 1:500 dilution for 2 h at room temperature. Nuclei were counterstained with DAPI when necessary. Images were taken using conventional fluorescence microscopes (Olympus BX-61 and Keyence), and the confocal pictures were taken using Fluoview FV 1000 (Olympus). All image analyses were conducted by an experimenter blinded to the source of the samples.
Tissue dissection and flow cytometry.
Following inclusion in the study, tissue samples were processed for flow cytometry and scRNA-seq as described below and, if enough tissue was available, for paraffin-embedding. All processing steps were performed on ice. Under the binocular lens, the leptomeninges were removed and, if both regions were present, gray and white matter tissue samples were dissected. Afterwards, tissue samples were placed in ice-cold HBSS containing 10 mM glucose and 10 mM HEPES buffer. Cell suspensions were obtained through mechanical dissociation using glass shearing with a 10-ml Potter-Elvehjem pestle and glass tube homogenizer (Merck) followed by passing through a 70-µm cell strainer (BD Bioscience). Myeloid cells were separated using a 37% Percoll (Merck) gradient from the homogenized tissue. Cell pellets were cryopreserved in FCS:dimethylsulfoxide (9:1; Merck) until further processing. To minimize batch effects, sample processing was conducted in a blocked manner, whereby control and diseased tissue samples were processed together. Also, where possible, several control tissue samples were processed on the same day. Cell sorting was performed using a MoFlo Astrios instrument (Beckman Coulter). The following antibodies were used for cell surface marker detection: anti-CD45 (clone HI30, BD Bioscience), anti-CD11b (clone M1/70, eBioscience), anti-CD3 (clone SP34-2, BD Bioscience), anti-CD19 (clone SJ25C1, BioLegend) and anti-CD20 (clone 2H7, BioLegend). Before surface staining, Fc receptors were blocked (BD Bioscience). Dead cells were stained using DAPI. scRNA amplification and library preparation. Single-cell suspensions were subjected to single-cell sorting using a MoFlow Astrios machine. After lineage exclusion (CD3e, CD19 and CD20), all CD45 + cells were sorted into 384-well plates (Bio-Rad). scRNA-seq was performed using an automated and miniaturized mCEL-Seq2 protocol on a mosquito nanoliter-scale liquid-handling robot 35, 52 . Eight libraries with 192 cells each were sequenced per lane on an Illumina HiSeq 3000 sequencing system (pair-end multiplexing run) at a depth of ~130,000-200,000 reads per cell.
Quantification of transcript abundance. Transcriptome alignment of pairedend reads was achieved using bwa (v.0.6.2-r126) with default parameters 53 . The transcriptome contained all gene models based on the human ENCODE V24 release. All isoforms of the same gene were treated as a single gene locus. The right mate of each read pair was mapped to the ensemble of all gene loci and to the set of 92 ERCC spike-ins in the sense direction 54 . Reads mapping to multiple loci were discarded. The left read contained the following barcode information: the first six bases represented the unique molecular identifier (UMI) followed by six bases with the cell-specific barcode. A polyT stretch comprised the remainder of the left read that was therefore not used for quantification. The number of UMIs per transcript was aggregated for each gene locus and assigned to individual cells depending on the barcode. Binomial statistics were used to model transcript counts from the number of observed UMIs 55 .
scRNA-seq data analysis. Data collection and analyses were performed in an unsupervised manner, but not blinded to the conditions of the experiments. Only cells expressing microglia markers were included in the analysis (nonmicroglial cells were excluded). A total of 72 libraries were sequenced, and 6,417 cells (4,564 healthy cells, 1,853 glioma cells) were analyzed after quality control. The number of quantified genes was 31,799 for healthy and 28,289 for gliomaassociated microglia. Data analysis and visualization were performed using the RaceID3 algorithm with 40 principal components 35 . Cells with a total number of transcripts of <1,500 were discarded, and gene counts of the remaining cells were normalized by downscaling. Before normalization, cells expressing >2% of KCNQ1OT1 transcripts, a previously identified 37 marker of low-quality cells, were removed from analysis. Likewise, transcripts correlating to KCNQ1OT1 with a Pearson's correlation coefficient of >0.65 were removed. The following parameters were used for RaceID3 analysis: mintotal = 1,500, minexpr = 5, outminc = 5, probthr = 10 −8 . We regressed out technical differences between the batches by passing the information that batches were processed and sequenced together to the VarRegression() function of RaceID3 (see Supplementary Tables 1 and 6 for batch information). The following genes were excluded from clustering as they likely represented dissociation-induced human genes, similar to previously published 37,38 murine dissociation-induced genes: DNAJB1, DUSP1, FOS, FOSB, H3F3B, HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPA5, HSPA6, HSPA8, HSPB1, IVNS1ABP, JUN, JUNB, MALAT1, RP11-212I21.4, RPS16 and ZFP36L1. Differentially expressed genes between two clusters were identified as previously described 56 . First, negative binomial distributions were inferred for the gene expression variability based on a background model computed by RaceID3 (ref. 35 ). Then, a P value for the observed difference in transcript counts was calculated. Correction for multiple testing was performed using the Benjamini-Hochberg method.
StemID2. StemID2 analysis was performed as previously described 37 with the default parameters except for 'nmode = TRUE, fast = TRUE' in the projcells(), projback(), lineagetree() and comppvalue() functions. For trajectory identification, all links with scthr = 0.75 were considered. For the trajectory, genes were filtered using the parameters 'minexpr = 4,minnumber = 1' in the filterset() function.
Monocle. Monocle pseudotime analysis 46 was conducted to independently validate the findings obtained using StemID2. Default parameters were used. Only genes expressed in at least 50 cells at a min_expr = 0.5 were considered. Dimensionality reduction was achieved with 'num_dim = 6' using the t-SNE method. Ordering genes for pseudotemporal ordering were obtained from the differentialGeneTest() function that was run for the 'Diagnosis' variable (with two levels, 'Healthy' and 'GMB' , depending on which patient the cells came from). Only genes with a qval of <0.01 were considered.
Cross-dataset comparisons. To achieve a quantitative comparison of our data to published datasets, we implemented a deep-neural-network-based classifier approach. The general principle was to obtain cluster assignment to one of the clusters described in this study for any given microglia transcriptome. This meant that the input dataset was a gene count matrix and the output dataset was a probabilistic assignment to a cluster that best represents the input data. The classifier was implemented using the keras R package 57 , which serves as an R interface to Tensorflow 58 . For training, we utilized a normalized counts matrix with columns containing genes that are expressed at five or more normalized counts in at least one cell and row containing cells. According to these criteria, the control dataset was trained on 792 genes and the GAM dataset on 463 genes. Before training, the dataset was split into a training and test dataset at a ratio of 0.7:0.3. The test dataset was held out during training for post hoc assessment of the classification accuracy. Preprocessing steps and network geometry were modified from existing approaches 59 . Input data were normalized, scaled up to 10,000 and log 2 -transformed. The network contained an input, 3 hidden layers with 100, 50 and 25 nodes and an output layer ( Supplementary Fig. 5a ). Rectified linear unit functions were used as activation functions for the hidden layers and softmax function was used for the output layer. Categorical cross entropy was used as the loss function and adaptive moment estimation as the optimizer. Accuracy was chosen as optimization metrics. The model was trained for 300 epochs with a batch size of 128 and a validation split of 0.2. Default settings were chosen for the remaining parameters. Raw gene counts from independent datasets were filtered for the genes used for the training of the classifier. Individual missing values were imputed using means from the training set. The classifier output was visualized using Marimekko charts.
Data analysis and visualization. Data collection and analyses were performed in an unsupervised manner, but not blinded to the conditions of the experiments. Only cells expressing microglia markers were included in the analysis (nonmicroglial cells were excluded). Data analysis was conducted using the R programming language 60 v.3.6.1 and GraphPad Prism 6.07. The tidyverse R ResouRce NATuRE NEuRoSCiENCE package was used for data processing and visualization (https://CRAN.R-project. org/package=tidyverse). GO term analysis was conducted using the clusterProfiler R package 51 . The code for Marimekko plots was modified from R. Scavetta (https:// campus.datacamp.com/courses/data-visualization-with-ggplot2-2/chapter-5-casestudy?ex=10).
Intracellular barcoding for mass cytometry.
Percoll-isolated myeloid cells were fixed with fixation/stabilization buffer 11 (SmartTube) and frozen at −80 °C until analysis by mass cytometry. Cells were thawed and subsequently stained with premade combinations of the following six different palladium isotopes: 102 Pd, 104 Pd, 105 Pd, 106 Pd, 108 Pd and 110 Pd (Cell-ID 20-plex Pd Barcoding kit, Fluidigm). This multiplexing kit applies a 6-choose-3 barcoding scheme that results in 20 different combinations of three Pd isotopes. After 30 min of staining (at room temperature), individual samples were washed twice with cell staining buffer (0.5% BSA in PBS, containing 2 mM EDTA). All samples were pooled together, washed and further stained with antibodies.
Antibodies. Anti-human antibodies ( Supplementary Tables 11 and 12 ) were purchased either preconjugated to metal isotopes (Fluidigm) or from commercial suppliers in purified form and conjugated in-house using a MaxPar X8 kit (Fluidigm) according to the manufacturer's protocol. For surface and intracellular staining, after cell barcoding, washing and pelleting, the combined samples were re-suspended in 100 µl of antibody cocktail against surface markers ( Supplementary Tables 11 and 12 ) and incubated for 30 min at 4 °C. Then, cells were washed twice with cell staining buffer. For intracellular staining, the stained (non-stimulated) cells were then incubated in fixation/permeabilization buffer (Fix/Perm Buffer, eBioscience) for 60 min at 4 °C. Cells were then washed twice with permeabilization buffer (eBioscience). The samples were then stained with antibody cocktails against intracellular molecules in permeabilization buffer for 1 h at 4 °C. Cells were subsequently washed twice with permeabilization buffer and incubated overnight in 2% methanol-free formaldehyde solution. Fixed cells were then washed and re-suspended in 1 ml of iridium intercalator solution (Fluidigm) for 1 h at room temperature. Next, the samples were washed twice with cell staining buffer and then twice with ddH 2 O (Fluidigm). Cells were pelleted and kept at 4 °C until CyTOF measurement.
CyTOF measurement. Cells were analyzed using a CyTOF2 instrument upgraded to Helios specifications with software v.6.5.236. The instrument was tuned according to the manufacturer's instructions with tuning solution (Fluidigm), and measurement of EQ four element calibration beads (Fluidigm) containing 140/142 Ce, 151/153 Eu, 165 Ho and 175/176 Lu served as a quality control for sensitivity and recovery. Immediately before analysis, cells were re-suspended in ddH 2 O, filtered (20 µm Celltrix, Sysmex), counted and adjusted to 3-5 × 10 5 cells ml -1 . EQ four element calibration beads were added at a final concentration of 1:10 of the sample volume to be able to normalize the data to compensate for signal drift and day-to-day changes in instrument sensitivity.
Samples were acquired with a flow rate of 300-400 events s -1 . A lower convolution threshold was set to 400, with noise reduction mode on and celldefinition parameters set at an event duration of 10-150. The resulting flow cytometry standard (.fcs) files were normalized and randomized using the CyTOF software's internal fcs-processing module on the non-randomized ('original') data. Settings were used according to the default settings in the software with time interval normalization (100 s per minimum of 50 beads) and passport v.2. Intervals with fewer than 50 beads per 100 s were excluded from the resulting .fcs file.
Mass cytometry data processing and analysis. Cytobank was used for initial manual gating on live single cells. Nucleated single viable cells were manually gated by the DNA intercalators 191 Ir/ 193 Ir and event length. For debarcoding, Boolean gating was used to deconvolute individual samples according to the barcode combination. For gated human microglia from different individuals, the expression levels of each marker were assessed and visualized in heatmaps, dot plots and/or histograms. Microglia immune phenotypes were visualized using two-dimensional t-SNE maps generated from P2RY12 + (panel A) or TMEM119 + (panel B) pre-gated human microglia cells. For embedding, we used Cytobank's default hyperparameters (perplexity = 30, theta = 0.5 and 1,000 iterations). Fig. 1c , differential gene expression analysis was conducted using an approach implemented in the DESeq2 R package 61 . The underlying statistic is assumed to be negative binomial. The diffexpnb RaceID function was used. The top differentially expressed genes were chosen based on the log 2 -fold change.
Statistics. For
For Fig. 2a , hypergeometric testing for enrichment was conducted using the clusterProfiler R package 51 with default settings. Multiple testing was corrected and q values are provided. A total of 31,799 genes quantified in this dataset were used as background.
For Fig. 3b ,c, one-sided paired t-tests were utilized for statistical testing. Between 11 and 15 datapoints were compared for each protein. Multiple testing adjustment was achieved using the Benjamini-Hochberg method. Sample means and distributions were compared and a normal distribution was assumed, but not explicitly tested. For Fig. 3e , hypergeometric testing was applied using the phyper R function (see Supplementary Table 5b for the underlying cell numbers per cluster and region). The Benjamini-Hochberg method was used for multiple testing adjustment. For Fig. 3g , one-sided unpaired t-test was used followed by Sidak-Bonferroni correction for multiple testing. Sample means and distributions were compared and a normal distribution was assumed, but not explicitly tested. For Fig. 3i , hypergeometric testing was applied using the phyper R function (see Supplementary Tables 1 and 2 for the underlying cell numbers per age bin and cluster). The Benjamini-Hochberg method was used for multiple testing adjustment. For Fig. 3j , Spearman's correlation was used on n = 10 samples with 3-4 datapoints per age bin.
For Fig. 4d , differential gene expression analysis was conducted using an approach implemented in the DESeq2 R package 61 . The underlying statistic is assumed to be negative binomial. The diffexpnb RaceID function was used. The top differentially expressed genes were chosen based on the log 2 -fold change. For Fig. 4f , hypergeometric testing was applied using the phyper R function (see Supplementary Table 8b for the underlying cell numbers per diagnosis and cluster). The Benjamini-Hochberg method was used for multiple testing adjustment.
For Fig. 5b , one-sided paired t-tests were utilized for statistical testing. Up to 15 controls and 7 patients with GBM were compared for each protein. Multiple testing adjustment was achieved using the Benjamini-Hochberg method. Sample means and distributions were compared and a normal distribution was assumed, but not explicitly tested. For Fig. 5f , one-sided unpaired t-test was utilized. Samples from n = 4 controls and n = 7 patients with GBM were assessed. Sample means and distributions were compared and a normal distribution was assumed, but not explicitly tested.
For Fig. 6a , pseudotime analysis was conducted using the StemID2 R algorithm 37 . Gene set enrichment analysis was performed using the clusterProfiler R package 51 . For Fig. 6e ,f, one-sided unpaired t-test was used followed by Sidak-Bonferroni correction for multiple testing. Sample means and distributions were compared and a normal distribution was assumed, but not explicitly tested (see Supplementary Table 12 for results of statistical testing).
For Extended Data Fig. 7b , two-way analysis of variance and Tukey post hoc test were performed (see Supplementary Tables 1 and 2 for the underlying cell numbers per age bin and cluster). Expression means and distributions were compared and a normal distribution was assumed, but not explicitly tested.
For Supplementary Fig. 1 , statistical testing was conducted using two-way analysis of variance followed by Tukey post hoc test (see Supplementary  Table 8b for the underlying cell numbers per diagnosis and cluster). Expression means and distributions were compared and a normal distribution was assumed, but not explicitly tested.
For Supplementary Fig. 2a , hypergeometric testing for enrichment was conducted using the clusterProfiler R package 51 with default settings. Multiple testing was corrected and q values are provided. A total of 28,289 genes quantified in this dataset were used as background.
For Supplementary Fig. 5 , pseudotime analysis was conducted using the StemID2 R algorithm 37 .
For Supplementary Fig. 6a ,b, pseudotime analysis was performed using the monocle R package 46 with default settings. Diagnosis with the levels 'control' and 'GAM' was used to calculate the trajectory.
For Supplementary Fig. 8a -c, one-sided unpaired t-test was used followed by Sidak-Bonferroni correction for multiple testing. Sample means and distributions were compared and a normal distribution was assumed, but not explicitly tested (see Supplementary Table 12 for results of statistical testing).
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The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code Data collection bwa version 0.6.2-r126 for sequence alignment. http://bio-bwa.sourceforge.net/ A custom Perl script for the extraction of mRNA counts based on unique molecular identifiers. CyTOF acquisition software 6.5.236 Data analysis FACS data was analysed using FlowJo vX.0.7; CyTOF data was analysed using Cytobank (www.cytobank.org); The neuronal network classifier was implemented using Data analysis and visualization was conducted using GraphPad Prism 6.07 and R: RaceID3 for Single-cell RNA sequencing data analysis (https://github.com/dgrun/ RaceID3_StemID2) and the tidyverse packages for further data processing and visualization. Versions of the used packages: 
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